Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-24-000073

Chief Executive Officer sold 12,115 shares at $48.84 ($591,697)

  • Chief Executive Officer acquired 25,527 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Goff Brian · Chief Executive Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-06-05 Exercise or conversion : show line 1 in the form 10b5-1 +25,527 79,307 D
2024-06-05 Sale : show line 2 in the form 10b5-1 −12,115 $48.84 $591,697 67,192 D
Open-market sales · 12,115 sh · avg $48.84 · $591,697

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-06-05 Exercise or conversion : show line 3 in the form 10b5-1 Performance share units −25,527 76,583 D
Loading xslF345X05/wk-form4_1717791913.xml…